Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases

• Status: Completed
• Trial end date: 2022-06-10
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to evaluate the effectiveness of the use of the drug, containing Vitex agnus castus extract (VAC), in patients with fibrocystic breast disease . One hundred fifty women over 40 years old were randomized into patient (n=78) and control (n=72) groups. The groups were similar regarding age, nulliparity, menopause and abortion status, family history of breast cancer, alcohol consumption, and smoking. The patient group received two pills containing 200mg of VAC daily for six months, and all participants were evaluated by using a Visual Analogue Scale and ultrasound examination at baseline, 12th and 24th weeks.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nazgul Omarbayeva

Criteria

Inclusion Criteria:

• 18 to 80 years old

• Must be able to visit the investigators at the appointesssd time.

Exclusion Criteria:

• refused to sign informed consent

• pregnant and breastfeeding

• has severe chronic comorbid diseases (cancer, diabetes mellitus, systemic blood diseases, neuralgia, suffering from mental illness or legally incompetent, e.g.)

• participated in another clinical trial